ADP receptor antagonists as antiplatelet therapeutics

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.8, Iss.1, 2003-05, pp. : 93-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 749-770

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 207-221

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin-4 Receptor Antagonists as Potential Therapeutics in the Treatment of Cachexia

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1131-1136

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet ADP Receptors and their Antagonists

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 2, 2003-03 ,pp. : 145-148

Bentham Science Publishers

Access to resources Recommend Favorite

P2Y 12 ADP receptor antagonists after percutaneous coronary interventions P2Y 12 -ADP-Rezeptorantagonisten nach perkutanen Koronarinterventionen

By Trenk Dietmar

PHARMAKON, Vol. 1, Iss. 1, 2013-01 ,pp. : 53-60

Govi-Verlag

Access to resources Recommend Favorite